Ovesco named Financial Times Long-Term Growth Champion for the Second Consecutive Year

Tuebingen, 13.11.2025. Ovesco Endoscopy AG has been recognized as one of Europe’s Long-Term Growth Champions by the Financial Times and Statista for the second time. This prestigious list honors companies that have demonstrated remarkable and consistent sales growth over an extended period.

The “Long-Term Growth Champion” ranking identifies the top European companies with consistent and significant revenue increases. With a compound annual growth rate (CAGR) of 19,07% Ovesco once again ranks among the leading companies in the Healthcare & Life Sciences sector, a testament to its robust business model and innovation pipeline.

Being recognized with this award for the second time in a row underscores Ovesco’s sustained performance and its position as a pioneer and innovator in the field of flexible endoscopy. Ovesco continues to expand its presence worldwide with innovative products that improve patient outcomes and increase the possibilities of endoscopic interventions. Key to Ovesco’s success are products such as the OTSC®neo System for hemostasis and the closure of acute and chronic lesions as well as the FTRD® System, which enables minimally invasive, endoscopic full-thickness resection.

“In the medical field, growth is not about short-term gains; it’s about long-term trust. This repeated recognition as a Growth Champion validates our core philosophy: that by consistently investing in reliable, forward-thinking solutions, we build a healthier future for patients and a sustainable foundation for our company.”, says Professor Dr. Marc Schurr, CEO of Ovesco Endoscopy AG.

About Ovesco Endoscopy AG

Ovesco Endoscopy AG’s core competence is the development of endoluminal procedures and technologies that provide significant benefits for patients and users in the treatment of gastrointestinal diseases. Our employees strive to develop innovative products of excellent quality and exceptional customer benefit and bring them to the clinic. Ovesco develops, produces, and distributes instruments and systems for the treatment of gastrointestinal diseases.